The Disposables Revolution - The use of disposables has changed significantly in the biopharmaceutical industry. - BioPharm International

ADVERTISEMENT

The Disposables Revolution
The use of disposables has changed significantly in the biopharmaceutical industry.


BioPharm International
Volume 21, Issue 2

Miriam's experience with Stedim mirrors both my and Adam's experience. In my case, at Lonza in Slough, we had a big problem with buffer handling in stainless-steel containers. The use of hold bags for buffers streamlined the whole operation and freed up production floor space for more capacity. Early in his career, Adam worked for a small biotech company that did not have the money to put in a conventional facility. Adam worked with Biowhitakker, a bag supplier, to look into using them to provide bags for holding buffers. However, the challenges he faced were considerable: the bag designs were rudimentary and he had to work with Colder Products to sort out the methods for making aseptic connections. Adam used this experience to challenge the likes of Stedim and Pall to offer something better.

As the industry has matured and the suppliers have developed technologies for sterilization, design, and integration of components (filters, tubing, and aseptic connectors), acceptance for the use of disposables for handling solutions has become widespread. We have reached the point where handling solutions in bags is commoditized and every supplier must have the capability of providing solution-handling systems. The future challenges are technical, business, and cost related. From Adam's perspective, the technical focus for the future has to do with development of the disposable downstream components such as GE Healthcare's disposable column. This will complement the advances in disposable cell culture bioreactors and contribute to achieve a totally disposable process.

Leaving aside the technical challenges, Miriam's view is that although standards may be being set in the arena of extractables and leachables, and sterility requirements, there is currently little attempt by the suppliers to standardize across product ranges. Such standardization would allow the end user to interchange bags between two suppliers working with the same support container. Lack of standardization complicates both the qualification of multiple suppliers and supply chain management. Such cost and business-related issues will come into sharper focus as disposables integration becomes the norm. There is a need for an industry forum where interested parties can debate competing claims: the ISPE is to be commended for setting up a Community of Practice for disposables. I will be returning to these and other issues in the future columns and welcome your input.

Andrew Sinclair is the managing director of Biopharm Services, Chesham, Bucks, UK, +44 (0) 1494 793 243,
.1 International Society of Professional Engineers (ISPE) set up a Community of Practice for disposables in 2007 whose mission aims to create a global focal point of support for biopharmaceutical professionals working with single-use disposable technologies. http:// http://cop.ispe.org/COP/DisposablesCOP/


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here